CHARLOTTE, N.C. — Autologous hematopoietic stem cell transplant (aHSCT), pursued for decades as a potential cure for multiple sclerosis (MS), is associated in the modern era with a high potential for ...

Brain cells that help make us human are also uniquely vulnerable to multiple sclerosis. A newfound cellular repair kit can’t keep up with the disease’s damage, leading to the cell death that’s a ...

B cells can control responses of myeloid cells through the release of particular cytokines (small proteins that control the growth and activity of cells in the immune system), challenging the ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

In this study, patients with multiple sclerosis (MS) and the experimental autoimmune encephalomyelitis (EAE) mouse model of MS exhibited an accumulation of Th17 cells in the small intestine.

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading ...

American counterterrorism agencies are quietly monitoring suspected sleeper cells on U.S. soil in the wake of joint U.S.–Israel strikes on Iran, stepping up surveillance amid heightened fears of ...

Gilead Sciences is expanding its cell therapy pipeline and technological capabilities through the $7.8 billion acquisition of Arcellx, its partner in the development of a multiple myeloma treatment ...

A map of the immune cell landscape found in the bone marrow of patients with multiple myeloma could shed light on how the immune system interacts with cancerous plasma cells. It could also help ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with longer PFS, suggesting T-cell composition may serve as a biomarker to ...

Emerging immunotherapy treatments for multiple myeloma target B-cell maturation antigen (BCMA), a protein found on the surface of cancer cells. Multiple myeloma is a blood cancer that develops when ...